Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis. [electronic resource]
Producer: 20200218Description: 655-664 p. digitalISSN:- 1432-0428
- Adolescent
- Adult
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Area Under Curve
- Autoimmunity
- C-Peptide -- blood
- CD3 Complex -- immunology
- CD8-Positive T-Lymphocytes -- drug effects
- Child
- Cytokines -- metabolism
- Diabetes Mellitus, Type 1 -- blood
- Female
- Follow-Up Studies
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin -- metabolism
- Islets of Langerhans -- cytology
- Male
- Randomized Controlled Trials as Topic
- Remission Induction
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.